Technical Analysis for CTXR - Citius Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.17 | -11.42% | -0.02 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| New Downtrend | Bearish | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | -11.42% | |
| Calm After Storm | Range Contraction | -11.42% |
| Alert | Time |
|---|---|
| Rose Above Lower Bollinger Band | about 21 hours ago |
| 2x Volume Pace | about 21 hours ago |
| 1.5x Volume Pace | about 21 hours ago |
| Up 5% | about 21 hours ago |
| Up 3% | about 21 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 12/27/2024
Citius Pharmaceuticals, Inc. Description
Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective products, adjunctive cancer care, and prescription products. Its product candidates include Mino-Lok and Hydrocortisone-Lidocaine Cream. The Company's Mino-Lok is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter. The Company's Hydrocortisone-Lidocaine topical formulation provides anti-inflammation and anesthetic relief to persons suffering from hemorrhoids. Its Mino-Lok product for the treatment of catheter related bloodstream infections has completed Phase IIb and is entering Phase III trials. It is reformulating Hydrocortisone-Lidocaine product and will be entering Phase IIb trials in 2017. As of September 30, 2016, the Company had not generate any revenues.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Drugs Inflammation Catheter Antibiotics Cancer Care Care Products Prescription Product Prescription Products Acetamides Bloodstream Infections Lidocaine
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.07 |
| 52 Week Low | 0.16 |
| Average Volume | 1,770,536 |
| 200-Day Moving Average | 0.64 |
| 50-Day Moving Average | 0.41 |
| 20-Day Moving Average | 0.34 |
| 10-Day Moving Average | 0.32 |
| Average True Range | 0.06 |
| RSI (14) | 29.08 |
| ADX | 25.05 |
| +DI | 14.54 |
| -DI | 35.99 |
| Chandelier Exit (Long, 3 ATRs) | 0.34 |
| Chandelier Exit (Short, 3 ATRs) | 0.34 |
| Upper Bollinger Bands | 0.51 |
| Lower Bollinger Band | 0.18 |
| Percent B (%b) | -0.03 |
| BandWidth | 95.49 |
| MACD Line | -0.05 |
| MACD Signal Line | -0.03 |
| MACD Histogram | -0.0203 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.24 | ||||
| Resistance 3 (R3) | 0.25 | 0.23 | 0.23 | ||
| Resistance 2 (R2) | 0.23 | 0.21 | 0.23 | 0.23 | |
| Resistance 1 (R1) | 0.20 | 0.20 | 0.19 | 0.19 | 0.22 |
| Pivot Point | 0.18 | 0.18 | 0.17 | 0.18 | 0.18 |
| Support 1 (S1) | 0.15 | 0.16 | 0.14 | 0.15 | 0.12 |
| Support 2 (S2) | 0.13 | 0.15 | 0.13 | 0.11 | |
| Support 3 (S3) | 0.10 | 0.13 | 0.11 | ||
| Support 4 (S4) | 0.10 |
